|
|
||||||||
Ann Thorac Surg 2005;79:2202-2203
© 2005 The Society of Thoracic Surgeons
Acibadem Bakirkoy Hospital, Halit Ziya Usakligil cad. No. 1 BaKirkoy Istanbul, 34140, Turkey
(E-mail: ersinerek{at}hotmail.com).
We read with great interest the articles by Hartz [1], Kanter [2], and their colleagues summarizing their results with Medtronic Freestyle porcine aortic bioprostheses for right ventricular outflow tract (RVOT) reconstruction. Both groups stated that there was no increase in transvalvular gradients at a mean of 16 months [1] or 2.5 years [2] postoperatively. We agree with the suitability of stentless bioprostheses for RVOT reconstruction, but our data do not confirm their findings regarding durability of these conduits.
Between March 1996 and August 1999, we [3] used Medtronic Freestyle porcine aortic conduits in 27 patients for RVOT reconstruction. We observed a significant increase in peak transvalvular gradients at 20.9 ± 17.1 months of follow-up (9.1 ± 3.3 mm Hg versus 34 ± 17.6 mm Hg; p = 0.0015). Therefore, since August 1999, we have been looking for better alternatives. We began to use CryoLife Ross pulmonary heterografts (n = 15) and Medtronic Contegra pulmonary valved conduits (bovine jugular vein with a trileaflet venous valve) (n = 9). However, we have seen similar increases in transvalvular gradients with these grafts at midterm follow-up. To date, 6 patients have had a reoperation because of conduit stenosis (Medtronic Freestyle, n = 4; CryoLife Ross, n = 2). Mean time to reoperation was 48.1 ± 8.5 months (range, 36 to 60 months). At reoperation, all conduits were severely calcified (Fig 1).
|
| References |
|---|
|
|
|---|
Related Articles
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |